ISCET

International Society for Clinical Eye Tracking

Details of Meeting 2 (2023-05-30)

Region: Asia/Australasia

Date/time

Tuesday May 30th 2023 at 1800 NZST (New Zealand) / 1600 AEST (Eastern Australia) / 1500 JST (Japan) / 1200 (China / Western Australia) / 1130 IST (India) / 0800 CEST (Central Europe) / 0700 BST (UK).

Chaired by Larry Abel (Deakin University).

Agenda

The overarching purpose of this meeting was to provide an opportunity for similar discussion as during the first meeting, at a time suitable for the Indo-Pacific region. Therefore, the agenda contains some repetition of the first meeting.

Note that, although Google Meet was discussed as a decentralised alternative for meetings, it does not allow for meetings to be recorded without a paid subscription – finding a suitable ongoing meeting platform is an agenda item for discussion.

  • Welcome
  • Background to ISCET so far (presented by Matt Dunn)
  • Outline of the role ISCEV plays in developing guidance for clinical visual electrophysiology (presented by Ruth Hamilton)
  • Developing a mission statement for ISCET – e.g. to provide clinical guidance / represent the clinical eye tracking sector – anything else?
  • Which clinical tests would benefit from published guidance?
    • At the previous meeting, it was suggested that a single sub-discipline should be focused on first. Discussion of this strategy, and if so, suggestions of which sub-disclipine to begin with.
  • Discussion of ongoing arrangements for ISCET meetings, focusing on decentralisation and allowing input from all
    • Suitable meeting timings and rotation of time zones?
    • Platform – is Zoom suitable?
    • Rotating chairperson – volunteers solicited for future meetings.
  • Any other business

Meeting recording

Attendees

20 people attended the meeting, including clinicians and researchers.

Notes

  • Ruth Hamilton highlighted in her talk that:
    • ISCEV defines minimum standards only, and ISCET might want to consider the same in order to avoid being more prescriptive than necessary.
    • The existence of standards does not mean clinicians cannot continue to do things their own way, but are a set of defaults to follow in the absence of other constraints/preference.
    • There is a separate ISCEV standard for each test (e.g. VEP/ERG), whereas ISCET standards are likely to be separated by use case (e.g. disease of interest).
    • ISCEV splits international representation according to three regions: the Americas, Europe + Africa, and Asia + Australasia.
  • Other points raised during discussion:
    • Since most eye tracking tasks use the same technology, it may be possible to define ‘core’ standards which apply to all subdisciplines, and then have additional standards which apply for each use case.
    • Standards are only useful for tests that are currently used and for which there is clinical utility. ISCET will therefore need to determine the current extent of real-world clinical use of eye trackers, as this will inform where to focus efforts, at least initially.
    • Once it has been decided which area(s) to focus on, it may be worth forming small committees of 2-3 people who report back to the group with suggestions for discussion.
    • This meeting time seemed favourable for the Indo-Pacific region, at least to those in attendance (though note that some clinicians could not make this meeting time). For now, meeting times will rotate between the two (approximate) slots used so far, to enable representation from across the world.
    • Consider having regional representatives for ISCET, like ISCEV.
  • Each attendee at the meeting introduced their own area of clinical/research interest. There was representation for:
    • Neurological disorders
    • Nystagmus (many people)
    • Antisaccades
    • Saccadic reaction times
    • Fixational eye movements
    • Reading disability / dyslexia
    • Orthoptics
    • Ophthalmology
    • Audiology
    • Amblyopia
    • Cognitive impairment
    • Glaucoma
    • Vergence / diplopia
    • Neuropsychology

Next meeting

The next meeting will focus on determining:

  1. the current extent of clinical eye tracking internationally
  2. which disciplines would most benefit from standards
  3. which specific discipline/test to focus on initially

Chat

15:54:48 From Larry Abel: https://sites.google.com/view/clinicaleyetracking/home?pli=1

15:59:49 From Matt J Dunn: https://sites.google.com/view/clinicaleyetracking/home

16:55:59 From Matt J Dunn: https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=ISCET&A=1

17:01:09 From PremNandhini: Thanks for putting this together Larry & Matt & others

17:01:17 From Matt McDonald: Thank you!

17:01:31 From Shrikant Bharadwaj: Thank very much!

17:01:37 From Priyanka Maniarasu: Thank you

17:01:38 From Leung Tsz Wing: Thank you